These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 643889)

  • 1. Platelet aggregation and thromboxane A2 formation in cat platelet rich plasma.
    Marcinkiewicz E; Grodzińska L; Gryglewski RJ
    Pharmacol Res Commun; 1978 Jan; 10(1):1-12. PubMed ID: 643889
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
    Fitzpatrick FA; Gorman RR
    Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biosynthesis of prostaglandins and thromboxane in the blood platelets].
    Katori M
    Nihon Rinsho; 1978 Dec; 36(12):3805-12. PubMed ID: 372618
    [No Abstract]   [Full Text] [Related]  

  • 4. Why do some beta adrenergic agonists inhibit generation of thromboxane A2 in incubates of platelets with arachidonic acid?
    Chignard M; Vargaftig BB
    Biochem Pharmacol; 1978; 27(11):1603-6. PubMed ID: 29642
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide.
    Allan G; Eakins KE; Kulkarni PS; Levi R
    Br J Pharmacol; 1980; 71(1):157-64. PubMed ID: 6781572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production.
    Hornby EJ; Skidmore IF
    Biochem Pharmacol; 1982 Mar; 31(6):1158-60. PubMed ID: 7200773
    [No Abstract]   [Full Text] [Related]  

  • 7. Interference of transmethylation inhibitors with thromboxane synthesis in rat platelets: evidence for the requirement of a methyl transfer reaction in platelet activation.
    Lecompte T; Randon J; Chignard M; Vargaftig BB; Dray F
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():441-7. PubMed ID: 6221560
    [No Abstract]   [Full Text] [Related]  

  • 8. Thromboxane A2 biosynthesis during endotoxin-induced aggregation of platelets from normal and sensitized guinea-pigs.
    Bult H; Herman AG
    Agents Actions; 1979 Dec; 9(5-6):560-5. PubMed ID: 397765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin, thromboxane, and prostacyclin in rats: A dilemma resolved?
    Livio M; Villa S; de Gaetano G
    Lancet; 1978 Jun; 1(8077):1307. PubMed ID: 78064
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of TXA2 formed by blood platelets and PGX formed by blood vessels and formation of thrombi].
    Srivastava KC
    Ugeskr Laeger; 1977 Nov; 139(47):2815-6. PubMed ID: 339456
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man.
    Szczeklik A; Gryglewski RJ; Grodzińska L; Musiał J; Serwońska M; Marcinkiewicz E
    Thromb Res; 1979; 15(3-4):405-13. PubMed ID: 494154
    [No Abstract]   [Full Text] [Related]  

  • 12. Nicotinic acid inhibits thromboxane synthesis in platelets.
    Vincent JE; Zijlstra FJ
    Prostaglandins; 1978 Apr; 15(4):629-36. PubMed ID: 674694
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release.
    Mikhailidis DP; Jeremy JY; Barradas MA; Green N; Dandona P
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1495-8. PubMed ID: 6416473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of ischemic cat myocardium by CGS-13080, a selective potent thromboxane A2 synthesis inhibitor.
    Burke SE; DiCola G; Lefer AM
    J Cardiovasc Pharmacol; 1983; 5(5):842-7. PubMed ID: 6195474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits.
    Gryglewski RJ; Dembińska-Kièć A; Zmuda A; Gryglewska T
    Atherosclerosis; 1978 Dec; 31(4):385-94. PubMed ID: 365189
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
    Bode-Böger SM; Böger RH; Galland A; Frölich JC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
    Grodzińska L; Marcinkiewicz E
    Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
    [No Abstract]   [Full Text] [Related]  

  • 18. L8027 and 1-nonyl-imidazole as non-selective inhibitors of thromboxane synthesis.
    Prancan AV; Lefort J; Chignard M; Gerozissis K; Dray F; Vargaftig BB
    Eur J Pharmacol; 1979 Dec; 60(4):287-97. PubMed ID: 527664
    [No Abstract]   [Full Text] [Related]  

  • 19. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
    Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
    Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effect of cimetidine on ADP induced platelet aggregation and thromboxane A2 synthesis in man.
    Gachályi B; Tihanyi K; Vas A; Káldor A
    Thromb Res; 1984 Jul; 35(1):105-9. PubMed ID: 6474407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.